Get all your news in one place.
100's of premium titles.
One app.
Start reading
Daily Record
Daily Record
Health
Ketsuda Phoutinane & Jessica Knibbs

Dostarlimab explained after drug's incredible success in bowel cancer study

An unprecedented bowel cancer study resulted in all patients being rid of the disease thanks to an experimental drug.

The US study used a womb cancer drug known as dostarlimab in a trial with colorectal cancer patients.

Though the study was small, its results saw cancer vanishing in all 18 patients and tears of joy.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.